Evidence map›Paper›PMID 20520858›Full record

ReviewThe Analyst2010

Mass-spectrometry-based clinical proteomics--a review and prospective.

Carol E Parker, Terry W Pearson, N Leigh Anderson, Christoph H Borchers

Abstract readReview
In one paragraph

Review in The Analyst, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Urine biomarkers for necrotizing enterocolitis.Pediatric surgery international · 2015
    Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Carol E ParkerUniversity of Victoria-Genome British Columbia Proteomics Centre, Victoria, BC, Canada.
Terry W Pearson
N Leigh Anderson
Christoph H Borchers

Funding

Measuring Cancer Biomarker Candidates by Targeted MS and Ab EnrichmentU24CA126476 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI CARR, STEVEN A · 2006 to 2010
$14.6M
NCI NIH HHS 1U24 CA126476-04NCI NIH HHS U24 CA126476
6 · The paper itself

Abstract

This review reports on the current and emerging technologies for the use of mass-spectrometry-based proteomics in clinical applications.

Indexed as

Mass SpectrometryBiomarkersProteomicsBiomarkers

Identifiers

PMID20520858
PMCPMC2966304

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.